Suchergebnisse

John Leonard - Director - has a Medical Doctor from Johns Hopkins University School of Medicine and Bachelor in Biochemistry from University of Wisconsin-Madison.

Calvin Johnson - Senior Vice President, Public Health and Chief Medical Officer - has a PhD from Johns Hopkins University School of Medicine and Graduate Degree from Johns Hopkins Bloomberg School of Public Health.

Harold Paz - Director - hält ein Fellow in Pulmonary and Critical Care Medicine der Johns Hopkins University School of Medicine.

Davey Daniel - Chief Medical Officer - hält ein Medical Doctor der Johns Hopkins University School of Medicine.

Scot Roberts - Chief Scientific Officer - hält ein PhD in Pharmacology and Molecular Sciences der Johns Hopkins University School of Medicine.

David Wheadon - Chairman of the Board - has a Doctor of Medicine from Johns Hopkins University School of Medicine and Bachelor in Biology from Harvard College.

Suneil Hosmane - Vice President, Diagnostic Strategy - has a PhD in Biomedical Engineering from Johns Hopkins University School of Medicine and Master of Science in Electrical and Computer Engineering from University of Illinois at Urbana-Champaign.

Ponni Subbiah - Senior Vice President, Global Head of Medical Affairs and Chief Medical Officer - has a Fellowship, AIDS Neurology from Johns Hopkins University School of Medicine and Master of Public Health from Johns Hopkins Bloomberg School of Public Health.

Jay Parkinson - Chief Medical Officer - has a Master of Public Health from Johns Hopkins University School of Medicine and Bachelor in Biology from Washington University in St. Louis.

Helen Collins - Principal, National Head of Affordable Housing and Managing Director of Midlands Region - hält ein Medical Doctor der Johns Hopkins University School of Medicine.

Peter Kim - Director of Financial Planning & Analysis - has a PhD in Tumor Immunology from Johns Hopkins University School of Medicine and Bachelor in Chemistry & Biological Sciences from Cornell University.

Robert Gould - Chairman of the Board - has a Post-doctoral Research Neuropharmacolog from Johns Hopkins University School of Medicine and PhD Biochemistry from University of Iowa Roy J. and Lucille A. Carver College of Medicine.

David Wheadon - Director - has a Doctor of Medicine from Johns Hopkins University School of Medicine and Bachelor in Biology from Harvard College.

Joe Lewcock - Chief Scientific Officer - hält ein PhD in Molecular Biology & Genetics der Johns Hopkins University School of Medicine.

Stephen Kahane - Director - has a Internship & Residency from Johns Hopkins University School of Medicine and MS, Engineering from Johns Hopkins University.

George Peoples - Director - has a Doctor of Medicine from Johns Hopkins University School of Medicine and Surgical Oncology Fellowship from UT MD Anderson Cancer Center.

David Wheadon - Director - has a Doctor of Medicine from Johns Hopkins University School of Medicine and Bachelor in Biology from Harvard College.

Shao-Lee Lin - Director - has a PhD in Immunology from Johns Hopkins University School of Medicine and Doctor of Medicine from Johns Hopkins University School of Medicine.

John Leonard - President, Chief Executive Officer and Director - has a Medical Doctor from Johns Hopkins University School of Medicine and Bachelor in Biochemistry from University of Wisconsin-Madison.

Stephen Kahane - Director - has a Internship & Residency from Johns Hopkins University School of Medicine and MS, Engineering from Johns Hopkins University.

Helen Collins - Director - hält ein Medical Doctor der Johns Hopkins University School of Medicine.

Joe Lewcock - Director - hält ein PhD in Molecular Biology & Genetics der Johns Hopkins University School of Medicine.

Steve Harr - Director - has a Doctor of Medicine from Johns Hopkins University School of Medicine and Bachelor in Economics from College of the Holy Cross.

Tony Ho - Director - has a Doctor of Medicine from Johns Hopkins University School of Medicine and Bachelor of Science in Electrical Engineering from University of California, Los Angeles.

Blake Aftab - Chief Scientific Officer - has a PhD in Pharmacology & Molecular Sciences and Anti-Cancer Drug Development from Johns Hopkins University School of Medicine and Bachelor of Science in Pharmacology from University of California, Santa Barbara.